Example: Heart Attack

Search clinical trials for: Infliximab

Total 470 results

NCT04438382

Recruiting

Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis

Conditions: Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm; Steroid-Refractory Pneumonitis
NCT04425538

Recruiting

A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).

Conditions: COVID-19
NCT04407247

Recruiting

Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma

Conditions: Colitis; Lung Non-Small Cell Carcinoma; Malignant Genitourinary System Neoplasm; Malignant Solid Neoplasm; Melanoma
NCT04399382

Not yet recruiting

A Clinical Study to Evaluate the Efficacy of Biologics in SpA

Conditions: Spondyloarthritis (SpA)
NCT04378621

Not yet recruiting

Effect of Antiinflammatory Treatment Versus Hand Training on Neuropsychiatric Comorbidity in RA-patients

Conditions: Rheumatoid Arthritis; Pain; Fatigue; Cognitive Decline; Depression; Brain Diseases; Hand Rheumatism
NCT04372108

Recruiting

A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease

Conditions: Crohn Disease
NCT04344249

Recruiting

Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic

Conditions: IBD; COVID
NCT04331639

Not yet recruiting

High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy

Conditions: Inflammatory Bowel Disease; Crohn Disease; Ulcerative Colitis; Vitamin D Deficiency
NCT04312659

Recruiting

A Study of Infliximab in the Treatment of Chinese Children With Crohn's Disease

Conditions: Crohn Disease
NCT04305145

Not yet recruiting

Infliximab for Treatment of Ipilimumab Colitis

Conditions: Melanoma Stage III; Melanoma Stage IV; Side Effect of Drug; Colitis
NCT04272788

Completed

Association of Breg and Treg With the Clinical Effects of Infliximab in the Treatment of Patients With Crohn's Disease

Conditions: Crohn Disease
NCT04205643

Not yet recruiting

CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Ulcerative Colitis

Conditions: Ulcerative Colitis
NCT04196920

Active, not recruiting

Methotrexate-associated Anti-TNF Combination Therapy, the Neglected One !

Conditions: Chronic Inflammatory Bowel Disease
NCT04191707

Completed

Metabolomic Markers of Fatigue in Inflammatory Bowel Disease

Conditions: Fatigue; Inflammatory Bowel Disease; Ulcerative Colitis; Crohn Disease
NCT04178850

Recruiting

Clinical Comparative Study to Evaluate the Efficacy and Safety of Recombinant Anti-TNF-alpha Antibodies for Injection

Conditions: Rheumatoid Arthritis
NCT04165265

Recruiting

The Use of Web-app Constant-Care in Patients With Acute Severe Ulcerative Colitis Treated With Rescue Therapy

Conditions: Ulcerative Colitis; Telemedicine
NCT04150770

Active, not recruiting

A Clinical Trial of Infliximab for Childhood Uveitis

Conditions: Uveitis; Infliximab
NCT04131504

Recruiting

Precision Crohn's Disease Management Utilizing Predictive Protein Panels (ENvISION)

Conditions: Crohn's Disease; IBD
NCT04118556

Not yet recruiting

Decidua Stroma Cells for Steroid Resistent Acute Graft-versus-host Disease (GvHD) After Allogenic Stem-cell Transplantation (HSCT)

Conditions: GVHD, Acute
NCT04115423

Not yet recruiting

A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab

Conditions: Infection; Rheumatoid Arthritis
NCT04114188

Recruiting

Tacrolimus After rATG and Infliximab Induction Immunosuppression (RIMINI)

Conditions: Renal Transplant Rejection
NCT04109300

Not yet recruiting

Preemptive HLA Genotyping for the Safe Use of Infliximab-combination Therapy in Inflammatory Bowel Disease

Conditions: Inflammatory Bowel Diseases; Ulcerative Colitis; Crohn Disease
NCT03964883

Completed

Infliximab Blood Test in Crohn's Disease

Conditions: Crohn Disease
NCT03945019

Recruiting

CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Crohn's Disease

Conditions: Crohn's Disease
NCT03942861

Recruiting

Sonographic Assessment in Severe Ulcerative Colitis Patients Admitted for Intravenous Corticosteroids and Eligible for Infliximab Rescue Therapy; a Prospective Clinician-blinded Observational Study Protocol.

Conditions: Ulcerative Colitis; Ultrasound Therapy; Complications
NCT03937609

Recruiting

TITRATE (inducTIon for acuTe ulceRATivE Colitis)

Conditions: Colitis, Ulcerative
NCT03907631

Recruiting

Multi-centre Acute Severe Ulcerative Colitis Prospective Cohort Study (Elevate ASUC)

Conditions: Severe Ulcerative Colitis
NCT03890445

Recruiting

Real-world Study of Anti-TNFa Treatment Regimes of Hyrimoz or Zessly in Patients With Crohn´s Disease

Conditions: Crohn´s Disease
NCT03885713

Recruiting

Identification of Predictive Biomarkers for Response to Biologic Therapies in Inflammatory Bowel Disease

Conditions: Inflammatory Bowel Diseases; Crohn Disease; Ulcerative Colitis
NCT03886233

Not yet recruiting

Treatment Outcome of Uveitis in Autoimmune Diseases

Conditions: Autoimmune Uveitis
NCT03884439

Recruiting

Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)

Conditions: Crohn's Disease; Ulcerative Colitis
NCT03885037

Recruiting

Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Rheumatoid Arthritis)

Conditions: Rheumatoid Arthritis
NCT03885089

Recruiting

Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis)

Conditions: Psoriasis Vulgaris; Psoriasis Arthropathica; Pustular Psoriasis; Erythrodermic Psoriasis
NCT03863704

Recruiting

Transcutaneous VNS to Treat Pediatric IBD

Conditions: Crohn Disease; Ulcerative Colitis
NCT03839862

Recruiting

Faecal Analyses in Spondyloarthritis Therapy

Conditions: Spondyloarthropathies; Ankylosing Spondylitis
NCT03841942

Recruiting

Comparison of Trough Level- and Clinical-based Spacing of Infliximab Infusions in Patients With IBD in Deep Remission

Conditions: Inflammatory Bowel Diseases
NCT03818516

Suspended

Impact of Inflammation on Reward Circuits, Motivational Deficits and Negative Symptoms in Schizophrenia

Conditions: Schizophrenia
NCT03819296

Not yet recruiting

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Melanoma or Genitourinary Cancer

Conditions: Clinical Stage 0 Cutaneous Melanoma AJCC v8; Clinical Stage I Cutaneous Melanoma AJCC v8; Clinical Stage IA Cutaneous Melanoma AJCC v8; Clinical Stage IB Cutaneous Melanoma AJCC v8; Clinical Stage II Cutaneous Melanoma AJCC v8; Clinical Stage IIA Cutaneous Melanoma AJCC v8; Clinical Stage IIB Cutaneous Melanoma AJCC v8; Clinical Stage IIC Cutaneous Melanoma AJCC v8; Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Colitis; Diarrhea; Malignant Genitourinary System Neoplasm; Pathologic Stage 0 Cutaneous Melanoma AJCC v8; Pathologic Stage I Cutaneous Melanoma AJCC v8; Pathologic Stage IA Cutaneous Melanoma AJCC v8; Pathologic Stage IB Cutaneous Melanoma AJCC v8; Pathologic Stage II Cutaneous Melanoma AJCC v8; Pathologic Stage IIA Cutaneous Melanoma AJCC v8; Pathologic Stage IIB Cutaneous Melanoma AJCC v8; Pathologic Stage IIC Cutaneous Melanoma AJCC v8; Pathologic Stage III Cutaneous Melanoma AJCC v8; Pathologic Stage IIIA Cutaneous Melanoma AJCC v8; Pathologic Stage IIIB Cutaneous Melanoma AJCC v8; Pathologic Stage IIIC Cutaneous Melanoma AJCC v8; Pathologic Stage IIID Cutaneous Melanoma AJCC v8; Pathologic Stage IV Cutaneous Melanoma AJCC v8
NCT03801928

Completed

Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease

Conditions: Inflammatory Bowel Disease (IBD); Crohn's Disease (CD); Ulcerative Colitis (UC)
NCT03775824

Completed

Faecal Analyses in Rheumatoid Arthritis Therapy

Conditions: Rheumatoid Arthritis
NCT03769987

Recruiting

Registry for Advanced Sarcodiosis

Conditions: Sarcoidosis
NCT03765450

Recruiting

Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis

Conditions: Ulcerative Colitis
NCT03729674

Recruiting

Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs

Conditions: Rheumatoid Arthritis; Ankylosing Spondylitis; Ulcerative Colitis; Crohn's Disease
NCT03710486

Recruiting

A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn's Disease (CD) Participants

Conditions: Colitis, Ulcerative; Crohn Disease
NCT03707535

Active, not recruiting

To Compare the Efficacy, Pharmacokinetics and Safety Between CT-P13 and China Approved Remicade When Co-administered With Methotrexate in Patients With Active Rheumatoid Arthritis

Conditions: Rheumatoid Arthritis
NCT03704610

Recruiting

Efficacy of Remission-induction Regimen With Infliximab for Severe Extrathoracic Sarcoidosis (EFIRTES)

Conditions: Extrathoracic Sarcoidosis
NCT03704363

Recruiting

BackToBasic: Infliximab in Chronic Low Back Pain and Modic Changes

Conditions: Low Back Pain
NCT03684278

Recruiting

Randomised Treatment of Acute Pancreatitis With Infliximab: Double-blind Multi-centre Trial (RAPID-I)

Conditions: Acute Pancreatitis
NCT03681652

Recruiting

Post-Operative Crohn's Disease Outcome in Children

Conditions: Crohn Disease
NCT03679546

Recruiting

EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis

Conditions: Ulcerative Colitis

Search clinical trials for: Infliximab

Recent CRA jobs

Start-up CRA, Ukraine

Remote Site Monitor, Ukraine

Accounting Coordinator (Cambridge)

Associate Treasury Analyst (Cambridge)

Sr Safety Reporting Admin

Recruitment Coordinator (6-month)

CRA (Level I or II)

Clinical Trial Coord (Previuos called PA)

CRA (Level to be defined)

Assoc Biostatistician- Wayne PA